Trials / Completed
CompletedNCT02889302
An Additional Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
An Additional Phase III Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 203 (actual)
- Sponsor
- Kissei Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the superiority of KPS-0373 to placebo, and evaluate the safety of KPS-0373 in SCD patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KPS-0373 | 24 weeks |
| DRUG | Placebo | 24 weeks |
Timeline
- Start date
- 2016-11-15
- Primary completion
- 2018-03-01
- Completion
- 2018-03-01
- First posted
- 2016-09-05
- Last updated
- 2018-12-14
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02889302. Inclusion in this directory is not an endorsement.